Top

Published in:

01-08-2013 | Letter to the Editor

Comment on “Nutrient reference values for bioactives: new approaches needed? A conference report” (European Journal of Nutrition, April 2013, Volume 52, Issue 1 Supplement, pp 1–9)

Author: Paula R. Trumbo

Published in: European Journal of Nutrition | Issue 5/2013

Excerpt

I have read this article with much interest and would like to provide some clarification. The abstract of this article notes that the US Food and Drug Administration (FDA) sets a labeling value for dietary fiber based on the Institute of Medicine (IOM) Adequate Intake (AI). In 1993, FDA established a Daily Value for dietary fiber (25 g) based on a report from the Life Sciences Research Office (LSRO) that was published in 1987 [1]. Although the IOM set an AI for dietary fiber in 2002 [2], the current Daily Value for dietary fiber continues to be based on the 1987 LSRO report. …

Life Sciences Research Office, Federation of American Societies for Experimental Biology (1987) Physiological effects and health consequences of dietary fiber. Bethesda, MD

IOM (2002) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, Washington, DC

Title: Comment on “Nutrient reference values for bioactives: new approaches needed? A conference report” (European Journal of Nutrition, April 2013, Volume 52, Issue 1 Supplement, pp 1–9)
Author: Paula R. Trumbo
Publication date: 01-08-2013
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nutrition / Issue 5/2013
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-013-0537-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comment on “Nutrient reference values for bioactives: new approaches needed? A conference report” (European Journal of Nutrition, April 2013, Volume 52, Issue 1 Supplement, pp 1–9)

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2013

Long-term effects of a neonatal low-protein diet in rats on the number of macrophages in culture and the expression/production of fusion proteins

Mechanisms underlying the anti-wasting effect of l-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies

Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3′-diindolylmethene in human breast epithelial cell lines

Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial

An atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training

Factors associated with serum/plasma concentrations of vitamins A, C, E and carotenoids in older people throughout Europe: the EUREYE study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page